Publications scientifiques SARS-CoV-2 / Covid-19

Liste des publications scientifiques de l’Institut Pasteur relatives au coronavirus SARS-CoV-2 et à la maladie Covid-19.

Recent increase in atypical presentations of invasive meningococcal disease in FranceTaha S. ; Deghmane A.E. ; Taha M.K.2024BMC Infectious Diseases
24 (1), 640
Correction to: Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020–2022, Okinawa prefecture, Japan (BMC Infectious Diseases, (2024), 24, 1, (542), 10.1186/s12879-024-09427-5)Takayama Y. et al.2024BMC Infectious Diseases
24 (1), 621
Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodelingSaunders N. et al.2024Nature Communications
15 (1), 4996
Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020–2022, Okinawa prefecture, JapanTakayama Y. et al.2024BMC Infectious Diseases
24 (1), 542
Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older peoplePoisson J. et al.2024Immunity and Ageing
21 (1), 28
Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deathsBrault A. et al.2024BMC Infectious Diseases
24 (1), 467
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodiesIzadi A. et al.2024Nature Communications
15 (1), 3600
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionPlanas D. et al.2024Nature Communications
15 (1), 2254
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wavePouquet M. et al.2024Scientific Reports
14 (1), 5418
Assessing respiratory epidemic potential in French hospitals through collection of close contact data (April–June 2020)Shirreff G. et al.2024Scientific Reports
14 (1), 3702
SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional studyMendiboure V. et al.2024BMC Public Health
24 (1)
Contributions of the qualitative Qualicor study embedded in a cohort study on the circumstances of SARS-CoV 2 infection in FrancePerrey C. et al.2024Infectious Diseases Now
54 (6), 104943
Routes of SARS-Cov2 transmission in the intensive care unit: A multicentric prospective studyTandjaoui-Lambiotte Y. et al.2024Journal of Infection and Public Health
17 (8), 102454
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccinationDurier C. et al.2024Infectious Diseases Now
54 (5), 104886
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024Laniece Delaunay C. et al.2024Vaccine
42 (19), pp. 3931-3937
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2Planchais C. et al.2024iScience
27 (7), 110354
The RBPome of influenza A virus NP-mRNA reveals a role for TDP-43 in viral replicationDupont M. et al.2024Nucleic acids research
52 (12), pp. 7188-7210
Transient reemergence of Bordetella parapertussis in France in 2022Bouchez V. et al.2024Journal of medical microbiology
73 (7)
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older EuropeansLaniece Delaunay C. et al.2024JAMA network open
7 (7), pp. e2419258
Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airwayMitri C. et al.2024Microbes and Infection
26 (5-6), 105354
Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19Cavaillon J.M. ; Chousterman B.G. ; Skirecki T.2024Journal of Intensive Medicine
4 (3), pp. 326-340
High-throughput screening identifies broad-spectrum Coronavirus entry inhibitorsKhan S. et al.2024iScience
27 (6), 110019
Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective StudyFunk A. et al.2024Clinical Infectious Diseases
78 (6), pp. 1522-1530
The mission of COVARS: how to anticipate health risks within a "One Health" vision of the exposomeAutran B. et al.2024Medecine/Sciences
40 (6-7), pp. 485-486
Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236Fujita S. et al.2024eBioMedicine
104, 105181
A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific regionHuet K. et al.2024IJID Regions
11, 100373
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023Lazarus J.V. et al.2024Nature Medicine
30 (6), pp. 1559-1563
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyJourdes A. et al.2024Clinical Microbiology and Infection
30 (6), pp. 764-771
Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop reportNunes M.C. et al.2024Infectious Disease Modelling
9 (2), pp. 501-518
Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized TrialThilly N. et al.2024JAMA Network Open
7 (5), e2411938
Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in FranceLièvre G. et al.2024Vaccine
42 (14), pp. 3288-3299
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 diseaseNambulli S. et al.2024Journal of virology
98 (5), pp. e0176223
Geographic heterogeneity of SARS-CoV-2 circulation in Abidjan, Ivory Coast: a prospective studyDoumbia M. ; Sevede D. ; Kouakou V. ; Pineau P.2024Journal of Infection in Developing Countries
18 (5), pp. 679-686
Emergence failure of early epidemics: A mathematical modeling approachBreban R.2024PLoS ONE
19 (5 May), e0301415
Snapshot of Anti-SARS-CoV-2 IgG Antibodies in COVID-19 Recovered Patients in GuineaGrayo S. et al.2024Journal of Clinical Medicine
13 (10), 2965
The Bacterial Meningitis Epidemic in Banalia in the Democratic Republic of Congo in 2021Bita Fouda A.A. et al.2024Vaccines
12 (5), 461
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine modelBrunet J. et al.2024Journal of Virology
98 (5)
Predicting consequences of COVID-19 control measure de-escalation on nosocomial transmission and mortality: a modelling study in a French rehabilitation hospitalSmith D.R.M. et al.2024Journal of Hospital Infection
147, pp. 47-55
AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitorTrepte P. et al.2024Molecular Systems Biology
20 (4), pp. 428-457
TMPRSS2 is the receptor of seasonal coronavirus HKU1Saunders N. ; Schwartz O.2024Medecine/Sciences
40 (4), pp. 335-337
Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 PandemicValtuille Z. et al.2024JAMA network open
7 (4), pp. e247965
Revealing the hidden interplay: The unexplored relationship between fungi and viruses beyond HIV, SARS-CoV-2, and influenzaGhelfenstein-Ferreira T. ; Serris A. ; Salmona M. ; Lanternier F. ; Alanio A.2024Medical Mycology
62 (4), myae021
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling studyHartner A.M. et al.2024The Lancet Global Health
12 (4), pp. e563-e571
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicineCajander S. et al.2024The Lancet Respiratory Medicine
12 (4), pp. 305-322
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022Delaunay C.L. et al.2024Eurosurveillance
29 (13), 2300403
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variantsPlanas D. et al.2024Heliyon
10 (5), e27033
A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine PlatformsBen Hamouda W. et al.2024Tropical Medicine and Infectious Disease
9 (3), 61
Use of Herbal Medicine in French Guiana: Influences and Challenges for Prevention Strategies in the Context of the COVID-19 PandemicForsans G. et al.2024Journal of Herbal Medicine
44, 100848
Comparative reconstruction of SARS-CoV-2 transmission in three African countries using a mathematical model integrating immunity dataNaffeti B. et al.2024IJID Regions
10, pp. 100-107
Drug-induced hearing loss: Listening to the latest advancesReynard P. ; Thai-Van H.2024Therapies
79 (2), pp. 283-295
Epidemiology of reported cases of leptospirosis in the EU/EEA, 2010 to 2021Beauté J. et al.2024Eurosurveillance
29 (7)
Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control StudyMelenotte C. et al.2024Open Forum Infectious Diseases
11 (2), ofae012
Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality AssessmentThai-Van H. ; Bagheri H. ; Valnet-Rabier M.B.2024Vaccines
12 (2), 181
High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factorsTejiokem M.C. et al.2024Influenza and other Respiratory Viruses
18 (2), e13239
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiencyZhang L. et al.2024Cell
187 (3), pp. 596-608.e17
Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022Rakover A. et al.2024BMC public health
24 (1), pp. 325
Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023Jeworowski L.M. et al.2024Eurosurveillance
29 (2)
Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov)Araujo-Chaveron L. ; Olivier C. ; Pellissier G. ; Bouvet E. ; Mueller J.E.2024Vaccine10.1016/j.vaccine.2024.07.004
Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)] (Vaccine, (S0264410X24006443), (10.1016/j.vaccine.2024.05.067))Laniece Delaunay C. et al.2024Vaccine10.1016/j.vaccine.2024.06.056
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cellsBeaumont E. ; Müller-Trutwin M. ; Huot N.2024Genes and Immunity10.1038/s41435-024-00284-5
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolutionSubissi L. et al.2024Nature Medicine10.1038/s41591-024-02949-0
Implications of O-glycan modifications in the hinge region of a plant-produced SARS-CoV-2-IgA antibody on functionalityUetz P. et al.2024Frontiers in Bioengineering and Biotechnology
12, 1329018
Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemicKovacevic A. et al.2024eLife
13, e85701
Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variantsCoutant F. et al.2024Emerging Microbes and Infections
13 (1), 2307510
Viral Zoonoses: Interactions and Factors Driving Virus TransmissionErmonval M. ; Morand S.2024Viruses
16 (1), 9
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1Bolland W. et al.2024Journal of Virology
98 (1)
Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10Lapierre L.A. et al.2024Cells
13 (2), 126
The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in AfricaOsaigbovo I.I. et al.2024Medical Mycology
62 (1), myad141
A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ-binding motif to the cytoplasmNeitthoffer B. et al.2024Journal of Biological Chemistry
300 (1), 105575
Risk Factors for Community and Intrahousehold Transmission of SARS-CoV-2: Modeling in a Nationwide French Population-Based Cohort Study, the EpiCoV StudyNovelli S. et al.2024American Journal of Epidemiology
193 (1), pp. 134-148
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in childrenBastard P. et al.2024Journal of Experimental Medicine
221 (2), e20231353
Vaccine-preventable Pediatric Acute Bacterial Meningitis in France: A Time Series Analysis of a 19-Year Prospective National Surveillance NetworkRybak A. et al.2024Pediatric Infectious Disease Journal
43 (1), pp. 74-83
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling AnalysisLingas G. et al.2024Clinical Pharmacology and Therapeutics
115 (1), pp. 86-94
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsBastard P. et al.2023Science Immunology
8 (90), eabp8966
An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti–Epstein-Barr Virus Antibodies Toward SARS-CoV-2 SpikeChêne A. et al.2023Journal of Infectious Diseases
228 (12), pp. 1675-1679
Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2Bhargava A. et al.2023iScience
26 (12), 108449
TMPRSS2 is a functional receptor for human coronavirus HKU1Saunders N. et al.2023Nature
624 (7990), pp. 207-214
Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trialLeblanc J. et al.2023PLoS Medicine
20 (12), e1004317
Author Correction: Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants (Nature Communications, (2023), 10.1038/s41467-023-40228-7)de Melo G.D. et al.2023Nature Communications
14 (1), 8024
Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1Lassaunière R. et al.2023The Lancet Infectious Diseases
23 (12), pp. e509-e510
Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in FranceOudin Doglioni D. et al.2023Scientific Reports
13 (1), 19895
Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based studyTan-Lhernould L. et al.2023BMC Medicine
21 (1), 426
SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cellsHuot N. et al.2023Nature Immunology
24 (12), pp. 2068-2079
Impact of influenza immunity on the mortality among older adults hospitalized with COVID-19: a retrospective cohort studyCoulongeat M. et al.2023Clinical and Experimental Medicine
23 (8), pp. 4955-4965
The rapid rebound of invasive meningococcal disease in France at the end of 2022Taha S. et al.2023Journal of Infection and Public Health
16 (12), pp. 1954-1960
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsHaas K.M. et al.2023Nature Communications
14 (1), 6030
An Innovative AI-based primer design tool for precise and accurate detection of SARS-CoV-2 variants of concernPerez-Romero C.A. et al.2023Scientific Reports
13 (1), 15782
Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series AnalysisLafay C. et al.2023Journal of Pediatrics
263, 113682
Increased risk of infection reporting with anti-BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance studyContejean A. et al.2023American Journal of Hematology
98 (12), pp. E349-E353
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approachAbatematteo F.S. et al.2023Scientific Reports
13 (1), 12798
Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variantsde Melo G.D. et al.2023Nature Communications
14 (1), 4485
Longitudinal social contact data analysis: insights from 2 years of data collection in Belgium during the COVID-19 pandemicLoedy N. et al.2023BMC Public Health
23 (1), 1298
Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case–control studyGalmiche S. et al.2023BMC Public Health
23 (1), 1240
Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in FrancePaireau J. et al.2023BMC Infectious Diseases
23 (1), 190
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodiesPlanas D. et al.2023Nature Communications
14 (1), 824
Emotional and behavioral changes in French children during the COVID-19 pandemic: a retrospective studyLandman B. et al.2023Scientific Reports
13 (1), 2003
Modeling the impact of national and regional lockdowns on the 2020 spring wave of COVID-19 in FranceRoux J. ; Massonnaud C.R. ; Colizza V. ; Cauchemez S. ; Crépey P.2023Scientific Reports
13 (1), 1834
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiencyLe Voyer T. et al.2023Nature
623 (7988), pp. 803-813
Fast and Accurate Maximum‑Likelihood Estimation of Multi‑Type Birth–Death Epidemiological Models from Phylogenetic TreesZhukova A. ; Hecht F. ; Maday Y. ; Gascuel O.2023Systematic Biology
72 (6), pp. 1387-1402
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022Meslé M.M.I. et al.2023Influenza and other Respiratory Viruses
17 (11), e13219
The Wood equation allows consistent fitting of individual antibody-response profiles of Zika virus or SARS-CoV-2 infected patientsDenis J. et al.2023Heliyon
9 (11), e21945
How have mathematical models contributed to understanding the transmission and control of SARS-CoV-2 in healthcare settings? A systematic search and reviewSmith D.R.M. et al.2023Journal of Hospital Infection
141, pp. 132-141
A synthetic delivery vector for mucosal vaccinationBillet A. et al.2023Biomaterials
302, 122298
Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral ActivityJones T. et al.2023ACS Omega
8 (43), pp. 40817-40822
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsBruel T. et al.2023Med
4 (10), pp. 664-667
SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic reviewWiedenmann M. et al.2023BMJ Open
13 (10), e072280
A rapid qualitative methods assessment and reporting tool for epidemic response as the outcome of a rapid review and expert consultationDong D. et al.2023PLOS Global Public Health
3 (10 October), e0002320
SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivoMahé D. et al.2023Journal of Virology
97 (10)
Monitoring the reproductive number of COVID-19 in France: Comparative estimates from three datasetsBonaldi C. ; Fouillet A. ; Sommen C. ; Lévy-Bruhl D. ; Paireau J.2023PLoS ONE
18 (10 October), e0293585
Neuroimmunology of rabies: New insights into an ancient diseaseBastos V. et al.2023Journal of Medical Virology
95 (10), e29042
Neutralization, effector function and immune imprinting of Omicron variantsAddetia A. et al.2023Nature
621 (7979), pp. 592-601
Risk of SARS-CoV-2 Infection among Households with Children in France, 2020-2022Galmiche S. et al.2023JAMA Network Open
6 (9), pp. E2334084
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individualsSokal A. et al.2023Immunity
56 (9), pp. 2137-2151.e7
A second update on mapping the human genetic architecture of COVID-19Kanai M. et al.2023Nature
621 (7977), pp. E7-E26
Dissecting human population variation in single-cell responses to SARS-CoV-2Aquino Y. et al.2023Nature
621 (7977), pp. 120-128
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replicationLe Chevalier F. et al.2023Microbes and Infection
25 (7), 105142
The Many Hosts of Mycobacteria 9 (MHM9): A conference reportKlever A.M. et al.2023Tuberculosis
142, 102377
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS ConsortiumShaw D. et al.2023The Lancet Digital Health
5 (9), pp. e582-e593
Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021Ochida N. et al.2023IJID Regions
8, pp. 64-70
Lessons from COVID-19 for rescalable data collectionBhatia S. et al.2023The Lancet Infectious Diseases
23 (9), pp. e383-e388
Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adultsAraujo-Chaveron L. et al.2023Vaccine
41 (37), pp. 5412-5423
RESEARCH ARTICLE Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemicWasniewski M. et al.2023PLoS ONE
18 (8 August), e0290444
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primatesMarc A. et al.2023PLoS Computational Biology
19 (8 August), e1010721
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2Clairon Q. et al.2023PLoS Computational Biology
19 (8 August), e1011282
During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are ConcomitantCavaillon J.M.2023Clinical Reviews in Allergy and Immunology
65 (2), pp. 183-187
JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach StudyFrémond M.L. et al.2023Journal of Clinical Immunology
43 (6), pp. 1436-1447
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1Tsui J.L.H. et al.2023Science
381 (6655), pp. 336-343
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidicsBroketa M. et al.2023JCI Insight
8 (13), e166602
Animal Toxins: A Historical Outlook at the Institut Pasteur of ParisPopoff M.R. ; Faure G. ; Legout S. ; Ladant D.2023Toxins
15 (7), 462
Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysisValtuille Z. et al.2023eClinicalMedicine
61, 102078
Definition and clinical variability of SHANK3-related Phelan-McDermid syndromeSchön M. et al.2023European Journal of Medical Genetics
66 (7), 104754
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021Woudenberg T. et al.2023Eurosurveillance
28 (25), A4
Analyzing the Geometry and Dynamics of Viral Structures: A Review of Computational Approaches Based on Alpha Shape Theory, Normal Mode Analysis, and Poisson–Boltzmann TheoriesHsieh Y.C. ; Delarue M. ; Orland H. ; Koehl P.2023Viruses
15 (6), 1366
SARS-CoV-2 E and 3a Proteins Are Inducers of Pannexin CurrentsOliveira-Mendes B.B.R. et al.2023Cells
12 (11), 1474
Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling studySmith D.R.M. ; Shirreff G. ; Temime L. ; Opatowski L.2023PLoS Medicine
20 (6 June), e1004240
Emergence, spread and characterisation of the SARSCoV- 2 variant B.1.640 circulating in France, October 2021 to February 2022Picard G. et al.2023Eurosurveillance
28 (22)
Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate modelHérate C. et al.2023Heliyon
9 (6), e16664
Severe Bacterial Infection Initially Misdiagnosed as MIS-C: Caution NeededStanzelova A. et al.2023Pediatric Infectious Disease Journal
42 (6), pp. E201-E203
SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor studyGalmiche S. et al.2023The Lancet Microbe
4 (6), pp. e409-e417
Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of MartiniqueGbaguidi G.N. et al.2023Infectious Diseases Now
53 (4), 104690
Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in childrenAvramescu M. et al.2023Kidney International
103 (6), pp. 1193-1198
Reply to: The role of pets in SARS-CoV-2 transmission: an exploratory analysisGalmiche S. ; Charmet T. ; Mailles A. ; Fontanet A.2023Infection
51 (3), pp. 793-795
Community engagement: learning from low-income countriesKutalek R. ; Ahmed S.M. ; Kaawa-Mafigiri D. ; Giles-Vernick T.2023The Lancet
401 (10390), pp. 1767-1768
Highlights from the Inaugural HIV Reservoirs and Immune Control Conference, October 1st–4th 2023, Malahide IrelandO’Doherty U. ; Martinez-Picado J. ; Sáez-Cirión A.2023Pathogens and Immunity
8 (1), pp. 161-169
SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022Supplisson O. et al.2023Eurosurveillance
28 (18)
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumoniaGarcía-García A. et al.2023Journal of Experimental Medicine
220 (5), e20220170
Sick leave due to COVID-19 during the first pandemic wave in France, 2020Smith D.R.M. et al.2023Occupational and Environmental Medicine
80 (5), pp. 268-272
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: Data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registriesMachado P.M. et al.2023Annals of the Rheumatic Diseases
82 (5), pp. 698-709
A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the fieldCeruti A. et al.2023Journal of Clinical Virology
162, 105422
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineagesTouret F. et al.2023iScience
26 (4), 106413
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021Gallian P. et al.2023iScience
26 (4), 106222
SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19Temmam S. et al.2023EMBO Reports
24 (4), e56055
New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemicTeirlinck A.C. et al.2023European Respiratory Journal
61 (4), 2201569
Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammationPhilippe A. et al.2023Archives of Cardiovascular Diseases
116 (4), pp. 183-191
Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settingsBenabdessalem C. et al.2023Diagnostic Microbiology and Infectious Disease
105 (4), 115903
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccinesFraser R. ; Orta-Resendiz A. ; Mazein A. ; Dockrell D.H.2023Trends in Molecular Medicine
29 (4), pp. 255-267
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?Pons S. et al.2023Stem Cell Reviews and Reports
19 (3), pp. 585-600
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in FranceTamandjou Tchuem C.R. et al.2023Vaccine
41 (13), pp. 2280-2288
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variantsChauvin C. et al.2023iScience
26 (3), 106124
A specific molecular signature in SARS-CoV-2–infected kidney biopsiesIsnard P. et al.2023JCI Insight
8 (5), e165192
Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variantsVaid R. et al.2023Genome Research
33 (3), pp. 299-313
Lentiviral Vectors as a Vaccine Platform against Infectious DiseasesNemirov K. et al.2023Pharmaceutics
15 (3), 846
On the risk of further excluding outcast patient populations in South AmericaRuiz E. et al.2023Annals of Hepatology
28 (2), 100901
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gapsWong A. et al.2023PLoS Pathogens
19 (3), e1011167
Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infectionFraser R. ; Orta-Resendiz A. ; Mazein A. ; Dockrell D. ; Müller-Trutwin M.2023European Respiratory Review
32 (167), 220197
Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitroRousseaud A. et al.2023Nitric Oxide - Biology and Chemistry
132, pp. 27-33
Prognosis value of pupillometry in COVID-19 patients admitted in intensive care unitDaniel M. et al.2023Autonomic Neuroscience: Basic and Clinical
245, 103057
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenLee D. et al.2023Science
379 (6632), eabo3627
Drawing a pandemic vulnerabilities' map: The SoNAR-global Vulnerabilities Assessment digital and its outputVaccaro C. et al.2023Frontiers in Sociology
8, 1127647
Editorial: Modulation of the adaptive immune responses and chronicity of infections with enveloped virusesSaid E.A. ; Ancuta P. ; Routy J.P. ; Vartanian J.P. ; Al-Jabri A.A.2023Frontiers in Immunology
14, 1137399
Managing sources of error during pandemicsCauchemez S. ; Bosetti P. ; Cowling B.J.2023Science
379 (6631), pp. 437-439
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteriaRosain J. et al.2023Cell
186 (3), pp. 621-645.e33
Renal arcuate vein thrombosis-induced acute kidney injury: a rare multiple-Hit-mediated diseasePardinhas C. et al.2023Clinical Kidney Journal
16 (2), pp. 367-373
Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA ReplicationNakajima S. et al.2023Viruses
15 (2), 452
Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, FrancePérot P. et al.2023Emerging Infectious Diseases
29 (2), pp. 286-293
Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in TunisiaKharroubi G. et al.2023Archives of Virology
168 (2), 69
Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experimentSicsic J. ; Blondel S. ; Chyderiotis S. ; Langot F. ; Mueller J.E.2023European Journal of Health Economics
24 (1), pp. 81-98
Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: A French multi-centered prospective observational studyDobre D. et al.2023Psychological Medicine
53 (2), pp. 342-350
Design and synthesis of naturally-inspired SARS-CoV-2 inhibitorsHassan H. et al.2023RSC Medicinal Chemistry
14 (3), pp. 507-519
Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patientsHeyerdahl L.W. et al.2023Vaccine
41 (4), pp. 883-891
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccinationSokal A. et al.2023Journal of Experimental Medicine
220 (1), e20220258
Messenger RNA (mRNA) vaccination, model of transition from basic biology to medicineSansonetti P.J.2023Comptes Rendus - Biologies
346, pp. 69-74
African countries from the Pasteur Network reexamine their syndromic sentinel surveillance system associated with household contact within the AFROSCREEN programTejiokem M.C. et al.2023Frontiers in Public Health
11, 1292435
Epigenetic and gene regulatory functions of small RNAsCecere G.2023Comptes Rendus - Biologies
Environmental variation and genetic diversity contribute to population differences in immune responses to SARS-CoV-2 and COVID-19 riskRotival M. ; Quintana-Murci L.2023Genes and Immunity10.1038/s41435-023-00249-0
Umbrella Data Management Plans to Integrate FAIR Data : Lessons From the ISIDORe and BY-COVID Consortia for Pandemic PreparednessDavid R. et al.2023Data Science Journal
22, 35
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studiesFerjancic Z. et al.2023Journal of Enzyme Inhibition and Medicinal Chemistry
39 (1), 2289007
Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional StudyBougeard S. et al.2023JMIR Public Health and Surveillance
9 (1), e46898
SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1Zhou B. et al.2023Emerging Microbes and Infections
12 (2), 2245921
Parallel vaccine discourses in Guinea: ‘grounding’ social listening for a non-hegemonic global healthHeyerdahl L.W. et al.2023Critical Public Health
33 (5), pp. 579-593
More than one crisis: COVID-19 response actors navigating multi-dimensional crises in Flanders, BelgiumKattumana T. et al.2023Critical Public Health
33 (5), pp. 566-578
Divergent adaptive immune responses define two types of long COVIDKervevan J. et al.2023Frontiers in Immunology
14, 1221961
Reconstructing household transmission dynamics to estimate the infectiousness of asymptomatic influenza virus infectionsTsang T.K. et al.2023Proceedings of the National Academy of Sciences of the United States of America
120 (33), e2304750120
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination:Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting DatabaseThai-Van H. et al.2023JMIR Public Health and Surveillance
9, e45263
One assay to test them all: Multiplex assays for expansion of respiratory virus surveillanceBoukli N. et al.2023Frontiers in Medicine
10, 1161268
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants (Frontiers in Immunology, (2021), 12, (761250), 10.3389/fimmu.2021.761250)Vanhove B. et al.2023Frontiers in Immunology
14, 1208705
Genomic epidemiology of SARS-CoV-2 in Cambodia, January 2020 to February 2021Su Y.C.F. et al.2023Virus Evolution
9 (1), veac121
The effect of variation of individual infectiousness on SARS-CoV-2 transmission in householdsTsang T.K. et al.2023eLife
12, e82611
Impact and mitigation of sampling bias to determine viral spread: Evaluating discrete phylogeography through CTMC modeling and structured coalescent model approximationsLayan M. et al.2023Virus Evolution
9 (1), vead010
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disordersDenis J. et al.2023Frontiers in Immunology
14, 1140714
About Morgan Jouvenet's article: "Science and society in the time of the COVID-19 pandemic: Research on the natural origins of SARS-CoV-2"Bontems F.2023Natures Sciences Societes
365 (6455)
Embracing context: Lessons from designing a dialogue-based intervention to address vaccine hesitancyNguyen T.T. et al.2023Frontiers in Public Health
11, 1069199
Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement?Boluda S. et al.2023Free Neuropathology
4, 1
New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 VariantsMarchini A. et al.2023Viruses
15 (1), 206
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden HamstersVesin B. et al.2023Vaccines
11 (1), 12
Main modulators of COVID-19 epidemic in sub-Saharan AfricaZinsou B.E. et al.2023Heliyon
9 (1), e12727
Antibodies as drugs—a Keystone Symposia reportCable J. et al.2023Annals of the New York Academy of Sciences
1519 (1), pp. 153-166
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?Plocque A. et al.2023Drugs
83 (1), pp. 1-36
Effect of the COVID-19 pandemic on emergency gastrointestinal surgery in a university hospital in Paris over three consecutive years: A cohort studyPaktoris H. ; Montravers P. ; Rebibo L. ; Ribeiro L. ; Gouel-Chéron A.2023European Journal of Anaesthesiology
40 (1), pp. 60-63
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and FutunaBrault A. et al.2023The Lancet Regional Health - Western Pacific
30, 100634
Statistical Analysis of Post-Translational Modifications Quantified by Label-Free Proteomics Across Multiple Biological Conditions with R: Illustration from SARS-CoV-2 Infected CellsGiai Gianetto Q.2023Methods in Molecular Biology
2426, pp. 267-302
A proteome-scale map of the SARS-CoV-2–human contactomeKim D.K. et al.2023Nature Biotechnology
41 (1), pp. 140-149
The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri ruleColson P. et al.2023Journal of Medical Virology
95 (1), e28102
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodiesBruel T. et al.2022Cell Reports Medicine
3 (12), 100850
Louis Pasteur, COVID-19, and the social challenges of epidemicsGiles-Vernick T. ; Cheah P.Y. ; Matta G. ; Lima N.T.2022The Lancet
400 (10369), pp. 2166-2168
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infectionPlanas D. et al.2022Med
3 (12), pp. 838-847.e3
Impacts of the covid-19 pandemic on children and adolescentsTrebossen V. ; Khoury É. ; Delorme R.2022La Revue du praticien
72 (10), pp. 1067-1070
Viruses to rescue health: VaccinationTangy F. ; Tournier J.N.2022Medecine/Sciences
38 (12), pp. 1052-1060
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsDurier C. et al.2022Scientific Reports
12 (1), 20373
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severitySmith N. et al.2022Nature Communications
13 (1), 7254
Estimating the risk of incident SARS-CoV-2 infection among healthcare workers in quarantine hospitals: the Egyptian exampleJijón S. et al.2022Scientific Reports
12 (1), 19773
MEPSi: A tool for simulating tomograms of membrane-embedded proteinsRodríguez de Francisco B. ; Bezault A. ; Xu X.P. ; Hanein D. ; Volkmann N.2022Journal of Structural Biology
214 (4), 107921
Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysisPipoli da Fonseca J. et al.2022Scientific Reports
12 (1), 19274
Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021–22: a status-based multi-variant modelHaschka T. ; Vergu E. ; Roche B. ; Poletto C. ; Opatowski L.2022BMC Infectious Diseases
22 (1), 815
Meningococcal disease in North America: Updates from the Global Meningococcal InitiativeAsturias E.J. et al.2022Journal of Infection
85 (6), pp. 611-622
Database of SARS-CoV-2 and coronaviruses kinetics relevant for assessing persistence in food processing plantsLuong N.D.M. et al.2022Scientific Data
9 (1), 654
Temporary ICUs during the COVID-19 pandemic first wave: description of the cohort at a French centreZappella N. et al.2022BMC Anesthesiology
22 (1), 310
Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia reportCable J. et al.2022Annals of the New York Academy of Sciences
1518 (1), pp. 209-225
The effect of COVID certificates on vaccine uptake, health outcomes, and the economyOliu-Barton M. et al.2022Nature Communications
13 (1), 3942
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screenMac Kain A. et al.2022Nature Communications
13 (1), 2442
Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling studyRosello A. et al.2022BMC Infectious Diseases
22 (1), 324
Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19Faucher B. et al.2022Nature Communications
13 (1), 1414
Antibody escape and global spread of SARS-CoV-2 lineage A.27Kaleta T. et al.2022Nature Communications
13 (1), 1152
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to FranceBosetti P. et al.2022BMC Medicine
20 (1), 33
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak riskSmith D.R.M. et al.2022Nature Communications
13 (1), 236
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesPark Y.J. et al.2022Science
378 (6620), pp. 619-627
The DEAD box RNA helicase DDX42 is an intrinsic inhibitor of positive-strand RNA virusesBonaventure B. et al.2022EMBO Reports
23 (11), e54061
Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workersSarrigeorgiou I. et al.2022PLoS ONE
17 (11 November), e0277827
Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2Planchais C. et al.2022Protein Science
31 (11), e4447
Upward trend for “Microbes and infection”Dussurget O. ; Ojcius D.M.2022Microbes and Infection
24 (8), 105057
Dynamics of SARS-CoV-2 lineages in French Guiana in 2020–2021: 4 epidemic waves with cross-influences from Europe and South AmericaMiliu A. et al.2022Infection, Genetics and Evolution
105, 105370
The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 4Parodi L. et al.2022Genetics in Medicine
24 (11), pp. 2308-2317
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control studyBelan M. et al.2022Clinical Microbiology and Infection
28 (11), pp. 1471-1476
The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signalingLaplantine E. et al.2022iScience
25 (10), 105066
Rapid investigation of BA.4/BA.5 cases in FranceKouamen A.C. et al.2022Frontiers in Public Health
10, 1006631
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillanceTegally H. et al.2022Science
378 (6615), eabq5358
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 VariantsGellenoncourt S. et al.2022Journal of Virology
96 (19)
No durable impact of COVID-19 measures on the hospital burden of respiratory syncytial virus (France, 2018–2022)Fourgeaud J. et al.2022Journal of Infection
85 (4), pp. 436-480
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age childrenDelaunay-Moisan A. et al.2022Environmental Microbiology
24 (10), pp. 4725-4737
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosaVesin B. et al.2022Molecular Therapy
30 (9), pp. 2984-2997
Human Claudin-Derived Peptides Block the Membrane Fusion Process of Zika Virus and Are Broad Flavivirus InhibitorsZoladek J. et al.2022Microbiology Spectrum
10 (5)
Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic ControlMura M. ; Simon F. ; Pommier de Santi V. ; Tangy F. ; Tournier J.N.2022Vaccines
10 (9), 1555
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyBruel T. et al.2022eClinicalMedicine
51, 101576
Bronchiolitis epidemics in France during the SARS-CoV-2 pandemic: The 2020–2021 and 2021–2022 seasonsVaux S. et al.2022Infectious Diseases Now
52 (6), pp. 374-378
Olfactory outcomes in Zika virus-associated Guillain–Barré syndromeLazarini F. et al.2022European Journal of Neurology
29 (9), pp. 2823-2831
Postscript: A pandemic read on African health and environmental historiesGiles-Vernick T.2022Health and Place
77, 102846
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et alOuldali N. et al.2022Annals of the Rheumatic Diseases
81 (9), e160
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primatesMarlin R. et al.2022Nature communications
13 (1), pp. 5108
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-?Mathian A. et al.2022Annals of the Rheumatic Diseases
81 (12), pp. 1695-1703
The genetic and evolutionary determinants of COVID-19 susceptibilityKerner G. ; Quintana-Murci L.2022European Journal of Human Genetics
30 (8), pp. 915-921
Aspergillus detection in airways of ICU COVID-19 patients: To treat or not to treat?Bounhiol A. ; Pasquier G. ; Novara A. ; Bougnoux M.E. ; Dannaoui E.2022Journal of Medical Mycology
32 (3), 101290
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximabMorel A. et al.2022American Journal of Transplantation
22 (8), pp. 2099-2103
Author Correction: Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (Nature, (2022), 604, 7905, (330-336), 10.1038/s41586-022-04532-4)Temmam S. et al.2022Nature
607 (7920), pp. E19
Tunneling nanotubes provide a route for SARS-CoV-2 spreadingPepe A. ; Pietropaoli S. ; Vos M. ; Barba-Spaeth G. ; Zurzolo C.2022Science Advances
8 (29), eabo0171
C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virusWu Y. et al.2022iScience
25 (7), 104537
A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 MiceBrandys P. et al.2022Frontiers in Immunology
13, 912898
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2Planchais C. et al.2022Journal of Experimental Medicine
219 (7), e20220638
A close shave: How SARS-CoV-2 induces the loss of ciliaFonseca B.F. ; Chakrabarti L.A.2022Journal of Cell Biology
221 (7), e202206023
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat CellsAicher S.M. et al.2022Journal of Virology
96 (14)
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and VaccinationGarcia L. et al.2022Viruses
14 (7), 1491
Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2– Recovered Dialysis PatientsAttias P. et al.2022Clinical Journal of the American Society of Nephrology
17 (7), pp. 1008-1016
Modelling the response to vaccine in nonhuman primates to define SARS-CoV-2 mechanistic correlates of protectionAlexandre M. et al.2022eLife
11, e75427
Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 TransmissionShirreff G. ; Zahar J.R. ; Cauchemez S. ; Temime L. ; Opatowski L.2022Emerging Infectious Diseases
28 (7), pp. 1345-1354
Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational StudyLayan M. et al.2022American Journal of Epidemiology
191 (7), pp. 1224-1234
Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replicationTsuji G. et al.2022Journal of Pharmacological Sciences
149 (3), pp. 81-84
COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infectionBoudhabhay I. et al.2022Nephrology Dialysis Transplantation
37 (7), pp. 1357-1365
Screening and vaccination against COVID-19 to minimise school closure: a modelling studyColosi E. et al.2022The Lancet Infectious Diseases
22 (7), pp. 977-989
Aedes mosquitoes in the emerging threat of urban yellow fever transmissionGabiane G. ; Yen P.S. ; Failloux A.B.2022Reviews in Medical Virology
32 (4), e2333
Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: Strengths, challenges, and lessons learnedBagaria J. et al.2022Eurosurveillance
27 (26), 2100864
Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activationPosseme C. et al.2022Cell Reports
39 (13), 110989
Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020Matczak S. et al.2022Eurosurveillance
27 (25), 2100933
Comparing the age and sex trajectories of SARS-CoV-2 morbidity and mortality with other respiratory pathogensMetcalf C.J.E. et al.2022Royal Society Open Science
9 (6), 211498
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variantSokal A. et al.2022Immunity
55 (6), pp. 1096-1104.e4
Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020Talla C. et al.2022IJID Regions
3, pp. 117-125
Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in A Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and QuarantineVan Elslande J. et al.2022Viruses
14 (6), 1198
Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral MucormycosisSerris A. et al.2022Frontiers in Immunology
13, 900522
Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic OptionsZnaidia M. ; Demeret C. ; van der Werf S. ; Komarova A.V.2022Viruses
14 (6), 1247
Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with chronic inflammatory rheumatic diseasesGros C. et al.2022Revue du Rhumatisme (Edition Francaise)
89 (4), pp. 405-411
Public health issues and health rendezvous for migrants from conflict zones in Ukraine: A French practice guidelineVignier N. et al.2022Infectious Diseases Now
52 (4), pp. 193-201
An early warning system for emerging SARS-CoV-2 variantsSubissi L. et al.2022Nature Medicine
28 (6), pp. 1110-1115
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesBruel T. et al.2022Nature Medicine
28 (6), pp. 1297-1302
Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?Ayrolles A. et al.2022Neuropsychopharmacology Reports
42 (2), pp. 218-220
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Kissling E. et al.2022Eurosurveillance
27 (21), A1
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesManry J. et al.2022Proceedings of the National Academy of Sciences of the United States of America
119 (21), e2200413119
Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational studyPandolfi F. ; Guillemot D. ; Watier L. ; Brun-Buisson C.2022BMJ Open
12 (5), e058205
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibodyTorres J.L. et al.2022Proceedings of the National Academy of Sciences of the United States of America
119 (20), e2120976119
Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2Auerswald H. et al.2022Frontiers in Medicine
9, 864972
A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate ModelFovet C.M. et al.2022Frontiers in Immunology
13, 855230
An ensemble model based on early predictors to forecast COVID-19 health care demand in FrancePaireau J. et al.2022Proceedings of the National Academy of Sciences of the United States of America
119 (18), e2103302119
Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workersChouchana L. et al.2022Therapies
77 (3), pp. 371-373
SARS-CoV-2 Lineage A.27: New Data from African Countries and Dynamics in the Context of the COVID-19 PandemicChouikha A. et al.2022Viruses
14 (5), 1007
Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variantsBlanquart F. ; Hozé N. ; Cowling B.J. ; Débarre F. ; Cauchemez S.2022eLife
11, e75791
Occurrence and transmission potential of asymptomatic and presymptomatic SARSCoV-2 infections: Update of a living systematic review and meta-analysisBuitrago-Garcia D. et al.2022PLoS Medicine
19 (5), e1003987
What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in UgandaBonner K.E. et al.2022PLoS ONE
17 (5 May), e0268063
Studying severe long COVID to understand post-infectious disorders beyond COVID-19Brodin P. et al.2022Nature Medicine
28 (5), pp. 879-882
Outpatient Antibiotic Prescriptions in France: Patients and Providers Characteristics and Impact of the COVID-19 PandemicBara W. ; Brun-Buisson C. ; Coignard B. ; Watier L.2022Antibiotics
11 (5), 643
Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in FranceDecarreaux D. et al.2022Viruses
14 (5), 957
A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare projectMolino D. et al.2022Nature Medicine
28 (5), pp. 882-884
Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 PandemicDeghmane A.E. ; Taha M.K.2022Microorganisms
10 (5), 907
Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling studyChen Y. et al.2022The Lancet Infectious Diseases
22 (5), pp. 657-667
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipientsBenotmane I. et al.2022Kidney International
101 (5), pp. 1073-1076
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitorsChen K.Y. et al.2022Antiviral Research
201, 105272
Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafishKraus A. et al.2022Brain, Behavior, and Immunity
102, pp. 341-359
Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersRossignol J. et al.2022Journal of Allergy and Clinical Immunology: In Practice
10 (5), pp. 1356-1364.e2
First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022Maisa A. et al.2022Infectious Diseases Now
52 (3), pp. 160-164
Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseasesGros C. et al.2022Joint Bone Spine
89 (3), 105312
Bat coronaviruses related to SARS-CoV-2 and infectious for human cellsTemmam S. et al.2022Nature
604 (7905), pp. 330-336
Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020Debin M. et al.2022Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
27 (17)
Social conformism and confidence in systems as additional psychological antecedents of vaccination: a survey to explain intention for COVID-19 vaccination among healthcare and welfare sector workers, France, December 2020 to February 2021Moirangthem S. et al.2022Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
27 (17)
COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City TunisCherif I. et al.2022Diagnostics
12 (4), 971
Contributions of modelling for the control of COVID-19 nosocomial transmissionOpatowski L. ; Temime L.2022Anaesthesia Critical Care and Pain Medicine
41 (2), 101054
Epidemic models: why and how to use themSofonea M.T. ; Cauchemez S. ; Boëlle P.Y.2022Anaesthesia Critical Care and Pain Medicine
41 (2), 101048
Towards SARS-CoV-2 serotypes?Simon-Loriere E. ; Schwartz O.2022Nature Reviews Microbiology
20 (4), pp. 187-188
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISHRensen E. et al.2022Life Science Alliance
5 (4), 202101124
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosusMoyon Q. et al.2022Annals of the Rheumatic Diseases
81 (4), pp. 575-583
Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022Bastard J. et al.2022Eurosurveillance
27 (13)
The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia FormationRajah M.M. ; Bernier A. ; Buchrieser J. ; Schwartz O.2022Journal of Molecular Biology
434 (6), 167280
Discovery of Genes that Modulate Flavivirus Replication in an Interferon-Dependent Manner: Effectors of the anti-flavivirus responseLesage S. et al.2022Journal of Molecular Biology
434 (6), 167277
Human genetic and immunological determinants of critical COVID-19 pneumoniaZhang Q. et al.2022Nature
603 (7902), pp. 587-598
Association between growth of the SARS-CoV-2 epidemic and increased coughing rate in cold temperatures: Surveillance in Hokkaido, JapanInaida S. ; Paul R.2022BMJ Open
12 (3), e051534
Exploring Zebrafish Larvae as a COVID-19 Model: Probable Abortive SARS-CoV-2 Replication in the Swim BladderLaghi V. et al.2022Frontiers in Cellular and Infection Microbiology
12, 790851
COVID-19 vaccination, time for a second breath?Gerke C.E. ; Pulverer B. ; Sansonetti P.J.2022EMBO Molecular Medicine
14 (3), e15810
SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillanceMontagutelli X. ; van der Werf S. ; Rey F.A. ; Simon-Loriere E.2022EMBO Molecular Medicine
14 (3), e15558
Assessment of surveillance predictors for suspected respiratory syncytial virus, influenza and Streptococcus pneumoniae infections in children aged <5 years in MadagascarRazanajatovo N.H. et al.2022IJID Regions
2, pp. 82-89
COVID-19 and the Burden of Confinement on Women’s Health: A Comparison between France and the United StatesMerchant J. ; Vidal C.2022International Journal of Feminist Approaches to Bioethics
15 (1), pp. 119-122
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Saunders N. et al.2022eBioMedicine
77, 103934
Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis – Authors' replyGangneux J.P. et al.2022The Lancet Respiratory Medicine
10 (3), pp. e27
sgDI-tector: Defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAsDi Gioacchino A. et al.2022RNA
28 (3), pp. 277-289
Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?Dellière S. et al.2022Journal of Clinical Microbiology
60 (3), e02169-21
Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent mannerGarnier Y. et al.2022British Journal of Haematology
196 (5), pp. 1159-1169
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trialDelaugerre C. et al.2022The Lancet Infectious Diseases
22 (3), pp. 341-348
Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative reviewAlderson M.R. et al.2022Journal of Infection
84 (3), pp. 289-296
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature reviewBenhadid-Brahmi Y. et al.2022Journal of Medical Mycology
32 (1), 101231
SARS-CoV-2 Induces Cytokine Responses in Human BasophilsBonam S.R. et al.2022Frontiers in Immunology
13, 838448
Considerable escape of SARS-CoV-2 Omicron to antibody neutralizationPlanas D. et al.2022Nature
602 (7898), pp. 671-675
Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing ProteinsZhu Y. et al.2022Frontiers in Microbiology
13, 829094
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 VaccineGallais F. et al.2022Frontiers in Immunology
13, 790212
Conditionality of COVID-19 vaccine acceptance in European countriesHeyerdahl L.W. et al.2022Vaccine
40 (9), pp. 1191-1197
Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling studyDiarra M. et al.2022BMJ Global Health
7 (2), e007236
The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 DeletionsCooke J. et al.2022Frontiers in Neuroscience
16, 806990
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infectionSulbaran G. et al.2022Cell Reports Medicine
3 (2), 100528
Editorial: Balanced and Unbalanced Immune Response to Dengue Virus in Disease Protection and PathogenesisCantaert T. ; Jouvenet N. ; Diehl S.A.2022Frontiers in Immunology
13, 835731
Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-NeutralisationMiyara M. et al.2022Frontiers in Immunology
13, 790334
Early chains of transmission of COVID-19 in France, January to March 2020Paireau J. et al.2022Eurosurveillance
27 (6), 2001953
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020Alizon S. et al.2022Eurosurveillance
27 (6), 2100406
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myelomaHenriquez S. et al.2022Blood
139 (6), pp. 942-946
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal CohortVo H.T.M. et al.2022Frontiers in Immunology
13, 817905
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infectionSingh M. et al.2022EMBO Reports
23 (2), e54341
Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly ComplicationDanion F. et al.2022Open Forum Infectious Diseases
9 (2), ofab566
FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17DScheck M.K. et al.2022PLoS ONE
17 (2 February), e0262149
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID studyGangneux J.P. et al.2022The Lancet Respiratory Medicine
10 (2), pp. 180-190
High negative predictive value of RT-PCR in patients with high likelihood of SARS-CoV-2 infectionGalmiche S. et al.2022Infectious Diseases Now
52 (1), pp. 52-53
Severe COVID-19 is associated with hyperactivation of the alternative complement pathwayBoussier J. et al.2022Journal of Allergy and Clinical Immunology
149 (2), pp. 550-556.e2
Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load Than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?Bonnet C. et al.2022Life
12 (2), 163
Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in FranceGrant R. et al.2022The Lancet Regional Health - Europe
13, 100278
Author Correction: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (Nature Immunology, (2022), 23, 2, (159-164), 10.1038/s41590-021-01030-z)Andreakos E. et al.2022Nature Immunology
23 (2), pp. 341
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational studyFillâtre P. et al.2022Clinical Microbiology and Infection
28 (2), pp. 298.e9-298.e15
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infectionAndreakos E. et al.2022Nature Immunology
23 (2), pp. 159-164
The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage PositivityKovacevic A. ; Eggo R.M. ; Baguelin M. ; Domenech De Cellès M. ; Opatowski L.2022Journal of Infectious Diseases
225 (2), pp. 199-207
Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22Bosetti P. et al.2022Eurosurveillance
27 (1), 2101125
The Pasteurian contribution to the history of vaccinesSchwartz M.2022Comptes Rendus - Biologies
345 (3), pp. 93-107
Incidence and prevalence of coma in the UK and the USAKondziella D. et al.2022Brain Communications
4 (5), fcac188
Association of Nonpharmaceutical Interventions during the COVID-19 Pandemic with Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections among Children in FranceRybak A. et al.2022JAMA Network Open
, pp. E2218959
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 InfectionMaisonnasse P. et al.2022Gastro Hep Advances
1 (3), pp. 393-402
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseasesHadjadj J. et al.2022Annals of the Rheumatic Diseases
81 (5), pp. 720-728
Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection (Journal of Clinical Immunology, (2022), 42, 1, (25-27), 10.1007/s10875-021-01119-y)Rodero M.P. et al.2022Journal of Clinical Immunology
42 (1), pp. 28
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Samelson A.J. et al.2022Nature Cell Biology
24 (1), pp. 24-34
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I studyLaunay O. et al.2022eBioMedicine
75, 103810
Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission (Nature Medicine, (2021), 27, 11, (1854-1855), 10.1038/s41591-021-01545-w)Kraemer M.U.G. et al.2022Nature Medicine
28 (1), pp. 213
Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoproteinGransagne M. et al.2022Journal of Biological Chemistry
298 (1), 101290
Nicotinic receptors as SARS-CoV-2 spike co-receptors?Dormoy V. et al.2022Medical Hypotheses
158, 110741
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccinesOliu-Barton M. et al.2022The Lancet Global Health
10 (1), pp. e142-e147
Rethinking the Infodemic: Social Media and Offline Action in the COVID-19 PandemicHeyerdahl L.W. ; Lana B. ; Giles-Vernick T.2022Economics, Law, and Institutions in Asia Pacific
, pp. 73-82
The COVID-19 Outbreak and Public Health Issues: An Interdisciplinary ApproachSakuntabhai A. ; Thomann B.2022Economics, Law, and Institutions in Asia Pacific
, pp. 341-353
Integrating Social Sciences to Mitigate Against CovidPaul R. ; Telle O. ; Benkimoun S.2022Economics, Law, and Institutions in Asia Pacific
, pp. 47-71
Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 InfectionRodero M.P. et al.2022Journal of Clinical Immunology
42 (1), pp. 25-27
Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteasesTekpinar M. ; Yildirim A.2022Journal of Biomolecular Structure and Dynamics
40 (14), pp. 6243-6254
Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cellsBernhauerová V. ; Lisowski B. ; Rezelj V.V. ; Vignuzzi M.2021Journal of Theoretical Biology
531, 110895
Mapping the human genetic architecture of COVID-19Niemi M.E.K. et al.2021Nature
600 (7889), pp. 472-477
SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formationRajah M.M. et al.2021EMBO Journal
40 (24), e108944
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variantsSokal A. et al.2021Immunity
54 (12), pp. 2893-2907.e5
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic miceKu M.W. et al.2021EMBO Molecular Medicine
13 (12), e14459
Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2De Cellès M.D. ; Casalegno J.S. ; Lina B. ; Opatowski L.2021PeerJ
9, e12566
Lockdown impact on age-specific contact patterns and behaviours, France, April 2020Bosetti P. et al.2021Eurosurveillance
26 (48), 2001636
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patientsCrescenzo-Chaigne B. et al.2021Journal of Clinical Virology Plus
1 (4), 100041
Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemicDi Domenico L. et al.2021Communications Medicine
1 (1), 57
The Impact of the Online COVID-19 Infodemic on French Red Cross Actors' Field Engagement and Protective Behaviors: Mixed Methods StudyHeyerdahl L.W. ; Lana B. ; Giles-Vernick T.2021JMIR Infodemiology
1 (1), e27472
Influenza viruses and coronaviruses: Knowns, unknowns, and common research challengesTerrier O. et al.2021PLoS Pathogens
17 (12), e1010106
An anti-Covid-19 lentiviral vaccine candidate that can be administered by the nasal routeMajlessi L. ; Charneau P.2021Medecine/Sciences
37 (12), pp. 1172-1175
Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registryAeschlimann F.A. et al.2021Journal of Cardiovascular Magnetic Resonance
23 (1), 140
Aspergillus test profiles and mortality in critically ill covid-19 patientsErgün M. et al.2021Journal of Clinical Microbiology
59 (12), e01229-21
Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)Weiss A. et al.2021PLoS ONE
16 (12 December), e0260958
SARS-CoV-2 transmission across age groups in France and implications for controlTran Kiem C. et al.2021Nature Communications
12 (1), 6895
Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency departmentNguyenVan J.C. et al.2021Journal of Clinical Virology
145, 105021
Using secondary cases to characterize the severity of an emerging or re-emerging infectionTsang T.K. ; Wang C. ; Yang B. ; Cauchemez S. ; Cowling B.J.2021Nature Communications
12 (1), 6372
A novel SARS-CoV-2 related coronavirus in bats from CambodiaDelaune D. et al.2021Nature Communications
12 (1), 6563
Clash of the titans: interferons and SARS-CoV-2Jouvenet N. ; Goujon C. ; Banerjee A.2021Trends in Immunology
42 (12), pp. 1069-1072
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamstersFrantz P.N. et al.2021Nature Communications
12 (1), 6277
Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory careLeGoff J. et al.2021Scientific Reports
11 (1), 21126
A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countriesSera F. et al.2021Nature Communications
12 (1), 5968
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsMaisonnasse P. et al.2021Nature Communications
12 (1), 6097
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak*Frumholtz L. et al.2021British Journal of Dermatology
185 (6), pp. 1176-1185
Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletionsDudas G. et al.2021Nature Communications
12 (1), 5769
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potentialMeyer B. et al.2021Nature Communications
12 (1), 5553
Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemicCassius C. et al.2021British Journal of Dermatology
185 (6), pp. 1242-1244
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaquesMarlin R. et al.2021Nature Communications
12 (1), 5215
Impact of COVID-19 social distancing on viral infection in France: A delayed outbreak of RSVDelestrain C. et al.2021Pediatric Pulmonology
56 (12), pp. 3669-3673
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearanceRobinot R. et al.2021Nature Communications
12 (1), 4354
Platelet activation in critically ill COVID-19 patientsYatim N. et al.2021Annals of Intensive Care
11 (1), 113
Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North AfricaFares W. et al.2021BMC Genomics
22 (1), 540
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosisGoubet A.G. et al.2021Cell Death and Differentiation
28 (12), pp. 3297-3315
Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic waveLandier J. et al.2021Scientific Reports
11 (1), 12756
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patientsCourties A. et al.2021Scientific Reports
11 (1), 11886
Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemicGagneux-Brunon A. et al.2021Trials
22 (1), 373
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillanceLe Vu S. et al.2021Nature Communications
12 (1), 3025
Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around themde Laval F. et al.2021BMC Infectious Diseases
21 (1), 457
Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers (Nature Communications, (2021), 12, 1, (844), 10.1038/s41467-021-21111-9)Marot S. et al.2021Nature Communications
12 (1), 2824
Deciphering the state of immune silence in fatal COVID-19 patientsBost P. et al.2021Nature Communications
12 (1), 1428
Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French GuianaAndronico A. et al.2021Nature Communications
12 (1), 1634
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workersMarot S. et al.2021Nature Communications
12 (1), 844
Guidelines of the French Society of Otorhinolaryngology and Head and Neck Surgery (SFORL) for teleconsultation in patients with vertigo during the COVID-19 pandemicBertholon P. et al.2021Annales Francaises d'Oto-Rhino-Laryngologie et de Pathologie Cervico-Faciale
138 (6), pp. 462-468
Guidelines of the French Society of Otorhinolaryngology (SFORL) for teleconsultation in patients with vertigo during the COVID-19 pandemicBertholon P. et al.2021European Annals of Otorhinolaryngology, Head and Neck Diseases
138 (6), pp. 459-465
Atypical Prolonged Viral Shedding With Intra-Host SARS-CoV-2 Evolution in a Mildly Affected Symptomatic PatientCunha M.d.P. et al.2021Frontiers in Medicine
8, 760170
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes VariantsVanhove B. et al.2021Frontiers in Immunology
12, 761250
Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-2Rivière F. et al.2021Respiratory Medicine and Research
80, 100862
MALVIRUS: an integrated application for viral variant analysisCiccolella S. et al.2021BMC Bioinformatics
22, 625
Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-2Frédéric R. et al.2021Respiratory medicine and research
80, pp. 100862
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time since InfectionPelleau S. et al.2021Journal of Infectious Diseases
224 (9), pp. 1489-1499
Seroprevalence of anti-sars-cov-2 igg at the first epidemic peak in french guiana, july 2020Flamand C. et al.2021PLoS Neglected Tropical Diseases
15 (11), e0009945
Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical ValueVeyer D. et al.2021Clinical Infectious Diseases
73 (9), pp. E2890-E2897
Pdz-containing proteins targeted by the ace2 receptorCaillet-Saguy C. ; Wolff N.2021Viruses
13 (11), 2281
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumoniaGhanem M. et al.2021American Journal of Physiology - Lung Cellular and Molecular Physiology
321 (5), pp. L847-L858
“We Tried to Borrow Money, but No One Helped.” Assessing the Three-Delay Model Factors Affecting the Healthcare Service Delivery among Dengue Patients during COVID-19 Surge in a Public Tertiary Hospital: A Convergent Parallel Mixed Methods StudyLigsay A.D. et al.2021International Journal of Environmental Research and Public Health
18 (22), 11851
Monitoring key epidemiological parameters of SARS-CoV-2 transmissionKraemer M.U.G. et al.2021Nature Medicine
27 (11), pp. 1854-1855
Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in FranceLefèvre B. et al.2021The Lancet Healthy Longevity
2 (11), pp. e685-e687
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patientsSacconi A. et al.2021Cell Death and Disease
12 (11), 1019
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyMonel B. et al.2021EBioMedicine
73, 103637
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infectionSmith N. et al.2021Nature Immunology
22 (11), pp. 1428-1439
Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort studyKernéis S. et al.2021European Journal of Clinical Microbiology and Infectious Diseases
40 (11), pp. 2379-2388
Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in FranceFourgeaud J. et al.2021European Journal of Clinical Microbiology and Infectious Diseases
40 (11), pp. 2389-2395
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital MortalityGendron N. et al.2021Arthritis and Rheumatology
73 (11), pp. 1976-1985
Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trialsDautzenberg B. ; Levi A. ; Adler M. ; Gaillard R.2021Respiratory Medicine and Research
80, 100844
Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance SystemGuenver C. et al.2021Frontiers in Pediatrics
9, 745364
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in AfricaWilkinson E. et al.2021Science
374 (6566), pp. 423-431
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesWalls A.C. et al.2021Cell
184 (21), pp. 5432-5447.e16
Quantifying healthcare and welfare sector workers' preferences around COVID-19 vaccination: A cross-sectional, single-profile discrete-choice experiment in FranceDÍaz Luévano C. et al.2021BMJ Open
11 (10), e055148
Covid-19-associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: A retrospective multicenter observational cohort during the first french pandemic waveBretagne S. et al.2021Microbiology Spectrum
9 (2), e01138-21
COVID-19-related travel restrictions temporarily reduced the demand for rabies post-exposure prophylaxis in FranceParize P. et al.2021Journal of Travel Medicine
28 (7), taab127
COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanismsOstaszewski M. et al.2021Molecular Systems Biology
17 (10), e10387
New insights into human immunity from ancient genomicsKerner G. ; Patin E. ; Quintana-Murci L.2021Current Opinion in Immunology
72, pp. 116-125
Telemedicine in Audiology. Best practice recommendations from the French Society of Audiology (SFA) and the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL)Thai-Van H. et al.2021European Annals of Otorhinolaryngology, Head and Neck Diseases
138 (5), pp. 363-375
Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune responseRoßmann L. et al.2021Proceedings of the National Academy of Sciences of the United States of America
118 (39), e2103651118
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019Betton M. et al.2021Clinical Infectious Diseases
73 (6), pp. E1337-E1344
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Grzelak L. et al.2021Journal of Infectious Diseases
224 (6), pp. 983-988
Demographic and Clinical Characteristics Associated With Severity, Clinical Outcomes, and Mortality of COVID-19 Infection in GabonIroungou B.A. et al.2021JAMA Network Open
4 (9), pp. E2124190
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditisde Cevins C. et al.2021Med
2 (9), pp. 1072-1092.e7
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primatesZabaleta N. et al.2021Cell Host and Microbe
29 (9), pp. 1437-1453.e8
Broad sarbecovirus neutralization by a human monoclonal antibodyTortorici M.A. et al.2021Nature
597 (7874), pp. 103-108
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in FranceCharmet T. et al.2021The Lancet Regional Health - Europe
8, 100171
A bioluminescent 3clpro activity assay to monitor sars-cov-2 replication and identify inhibitorsMathieu C. et al.2021Viruses
13 (9), 1814
Twelfth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast CancerCharifou E. ; Traustadottir G.A. ; Bentires-Alj M. ; Howard B. ; Van Keymeulen A.2021Journal of Mammary Gland Biology and Neoplasia
26 (3), pp. 221-226
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionGallais F. et al.2021EBioMedicine
71, 103561
Managing COVID-19 importation risks in a heterogeneous worldCauchemez S. ; Kiem C.T.2021The Lancet Public Health
6 (9), pp. e626-e627
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionZahradník J. et al.2021Nature Microbiology
6 (9), pp. 1188-1198
ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loadsMarchio A. et al.2021Archives of Virology
166 (9), pp. 2529-2540
Characteristics Associated with Olfactory and Taste Disorders in COVID-19Galmiche S. et al.2021Neuroepidemiology
55 (5), pp. 381-386
A review of significance of Aspergillus detection in airways of ICU COVID-19 patientsPasquier G. et al.2021Mycoses
64 (9), pp. 980-988
ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2Van Kerkhove M.D. et al.2021Influenza and other Respiratory Viruses
15 (5), pp. 561-568
Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathwayGuedj E. et al.2021Clinical Microbiology and Infection
27 (9), pp. 1196-1198
Host PDZ-containing proteins targeted by SARS-CoV-2Caillet-Saguy C. et al.2021FEBS Journal
288 (17), pp. 5148-5162
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Parellada M. et al.2021Frontiers in Psychiatry
12, 701729
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Drayman N. et al.2021Science
373 (6557), pp. 931-936
Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergenceKraemer M.U.G. et al.2021Science
373 (6557), pp. 889-895
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19Asano T. et al.2021Science Immunology
6 (62), eabl4348
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsBastard P. et al.2021Science Immunology
6 (62), eabl4340
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationPlanas D. et al.2021Nature
596 (7871), pp. 276-280
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectinde Melo G.D. et al.2021EMBO Molecular Medicine
13 (8), e14122
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) from a BNT162b2-Vaccinated IndividualKerneís S. et al.2021Open Forum Infectious Diseases
8 (8), ofab369
Mitigating COVID-19 outbreaks in workplaces and schools by hybrid telecommutingMauras S. et al.2021PLoS Computational Biology
17 (8), e1009264
Covid-19 research: Lessons from non-human primate modelsAlbrecht L. et al.2021Vaccines
9 (8), 886
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infectionYatim N. et al.2021Science Advances
7 (34), eabg4081
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern FranceWoudenberg T. et al.2021EBioMedicine
70, 103495
Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control studyGalmiche S. et al.2021The Lancet Regional Health - Europe
7, 100148
Low seroprevalence of COVID-19 in Lao PDR, late 2020Virachith S. et al.2021The Lancet Regional Health - Western Pacific
13, 100197
A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measuresTran Kiem C. et al.2021eClinicalMedicine
38, 101001
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosisVerweij P.E. et al.2021Intensive Care Medicine
47 (8), pp. 819-834
The Nexus between Telomere Length and Lymphocyte Count in Seniors Hospitalized with COVID-19Benetos A. et al.2021Journals of Gerontology - Series A Biological Sciences and Medical Sciences
76 (8), pp. E97-E101
What chikungunya teaches us about COVID-19Simon F. ; Watson H. ; Meynard J.B. ; de Santi V.P. ; Tournier J.N.2021The Lancet Infectious Diseases
21 (8), pp. 1070-1071
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?Cohen R. et al.2021Infectious Diseases Now
51 (5), pp. 418-423
Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strainBillon-Denis E. et al.2021Infection
49 (4), pp. 781-783
Education and mental health: good reasons to vaccinate childrenCauchemez S. et al.2021The Lancet
398 (10298), pp. 387
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tummino T.A. et al.2021Science
373 (6554), 6554
SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interactionLavigne M. et al.2021Nucleic Acids Research
49 (13), pp. 7695-7712
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Kissling E. et al.2021Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
26 (29)
How did institut pasteur’s ngs core facility, biomics, manage the coronavirus disease 2019 crisis?Najjar I. et al.2021Journal of Biomolecular Techniques
32 (2), pp. 50-56
A mechanistic and data-driven reconstruction of the time-varying reproduction number: Application to the COVID-19 epidemicCazelles B. et al.2021PLoS Computational Biology
17 (7), e1009211
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-covid-19 worldToor J. et al.2021eLife
10, e67635
Nationwide seroprevalence of SARS-CoV-2 IgG antibodies among four groups of primary health-care workers and their household contacts 6 months after the initiation of the COVID-19 vaccination campaign in france: seroPRIM study protocolPouquet M. et al.2021Pathogens
10 (7), 911
Host-pathogen adhesion as the basis of innovative diagnostics for emerging pathogensvan Belkum A. et al.2021Diagnostics
11 (7), 1259
Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: A modelling study, France, May to September 2021Kiem C.T. et al.2021Eurosurveillance
5 (13)
Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021Tran Kiem C. et al.2021Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
26 (26)
A review and agenda for integrated disease models including social and behavioural factorsBedson J. et al.2021Nature Human Behaviour
5 (7), pp. 834-846
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourseKonings F. et al.2021Nature Microbiology
6 (7), pp. 821-823
Effectiveness of anaesthesia ventilator use for mechanical ventilation in critically ill patients during the COVID-19 pandemicGouel-Cheron A. et al.2021British Journal of Anaesthesia
127 (1), pp. e35-e37
Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020Kissling E. et al.2021Influenza and other Respiratory Viruses
15 (4), pp. 429-438
Interoperable medical data: The missing link for understanding COVID-19Bauer D.C. et al.2021Transboundary and Emerging Diseases
68 (4), pp. 1753-1760
COVID-Align: Accurate online alignment of hCoV-19 genomes using a profile HMMLemoine F. ; Blassel L. ; Voznica J. ; Gascuel O.2021Bioinformatics
37 (12), pp. 1761-1762
Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and EntryFirpo M.R. et al.2021ACS Infectious Diseases
7 (6), pp. 1423-1432
COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamstersde Melo G.D. et al.2021Science Translational Medicine
13 (596), eabf8396
Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysisLefrancq N. et al.2021The Lancet Regional Health - Europe
5, 100087
Lockdown as a last resort option in case of COVID-19 epidemic rebound: A modelling studyKiem C.T. et al.2021Eurosurveillance
26 (22)
Ivermectin as a potential treatment for covid-19?Chosidow O. et al.2021PLoS Neglected Tropical Diseases
15 (6), e0009446
The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2Di Gioacchino A. et al.2021Molecular Biology and Evolution
38 (6), pp. 2428-2445
COVID-19 containment measures and incidence of invasive bacterial diseaseSmith D.R.M. ; Opatowski L.2021The Lancet Digital Health
3 (6), pp. e331-e332
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance dataBrueggemann A.B. et al.2021The Lancet Digital Health
3 (6), pp. e360-e370
Diversity in immunogenomics: the value and the challengePeng K. et al.2021Nature Methods
18 (6), pp. 588-591
Structural basis for broad coronavirus neutralizationSauer M.M. et al.2021Nature Structural and Molecular Biology
28 (6), pp. 478-486
Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling studyHozé N. et al.2021The Lancet Public Health
6 (6), pp. e408-e415
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult populationLapidus N. et al.2021Infectious Diseases Now
51 (4), pp. 380-382
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2Vanhove B. et al.2021European Journal of Immunology
51 (6), pp. 1412-1422
Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortalityBernigaud C. et al.2021British Journal of Dermatology
184 (6), pp. 1207-1209
Heat inactivation of the severe acute respiratory syndrome coronavirus 2Batéjat C. ; Grassin Q. ; Manuguerra J.C. ; Leclercq I.2021Journal of Biosafety and Biosecurity
3 (1), pp. 1-3
Fungal infections should be part of the core outcome set for COVID-19Verweij P.E. ; Alanio A.2021The Lancet Infectious Diseases
21 (6), pp. e145
High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ householdsFritz M. et al.2021One Health
11, 100192
Ousted health care workers because of COVID-19 infection: Back to work is not an easy moveGOUEL-CHERON A. ; DEN BERGH M.V. ; CRESTANI B. ; MONTRAVERS P.2021Anaesthesia Critical Care and Pain Medicine
40 (3), 100752
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodiesDufloo J. et al.2021Cell Reports Medicine
2 (5), 100275
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternativesLe Hingrat Q. et al.2021Clinical Microbiology and Infection
27 (5), pp. 789.e1-789.e5
Complement inhibition in severe COVID-19 – Blocking C5a seems to be key: Author's replyAnnane D. ; Grimaldi-Bensouda L. ; Fremeaux-Bacchic V.2021EClinicalMedicine
35, 100866
Are posterior oropharyngeal saliva specimens an acceptable alternative to nasopharyngeal sampling for the monitoring of sars-cov-2 in primary-care settings?Masse S. et al.2021Viruses
13 (5), 761
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodiesPlanas D. et al.2021Nature Medicine
27 (5), pp. 917-924
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohortTubiana S. et al.2021Journal of Infection
82 (5), pp. 186-230
Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemicBerteloot L. et al.2021American Journal of Transplantation
21 (5), pp. 1937-1943
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohortDellière S. et al.2021Clinical Microbiology and Infection
27 (5), pp. 790.e1-790.e5
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2McCallum M. et al.2021Cell
184 (9), pp. 2332-2347.e16
VirologySaleh M.C. ; Rey F.A.2021Virology
, pp. 1-368
SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?Sancho-Shimizu V. et al.2021Journal of Experimental Medicine
218 (6), e20210446
Stealth Fluorescence Labeling for Live Microscopy Imaging of mRNA DeliveryBaladi T. et al.2021Journal of the American Chemical Society
143 (14), pp. 5413-5424
Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021Calba C. et al.2021Eurosurveillance
26 (13)
Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coliMadru C. et al.2021PLoS ONE
16 (4 April), e0250610
Virus eradication and synthetic biology: Changes with sars-cov-2?Tournier J.N. ; Kononchik J.2021Viruses
13 (4), 569
Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020Sermet-Gaudelus I. et al.2021Eurosurveillance
26 (13), 2001782
SARS-CoV-2 population-based seroprevalence studies in Europe: A scoping reviewGrant R. et al.2021BMJ Open
11 (4), e045425
Outcome of asymptomatic patients with positive SARS-CoV-2 viral RNA reverse transcriptase-PCR undergoing surgery: A matched cohort studyVerliere A. et al.2021European Journal of Anaesthesiology
38 (4), pp. 442-444
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumoniade Prost N. et al.2021Journal of Clinical Immunology
41 (3), pp. 536-544
Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional studyRoederer T. et al.2021The Lancet Public Health
6 (4), pp. e202-e209
Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, FranceToubiana J. et al.2021Journal of Clinical Immunology
41 (3), pp. 526-535
The presence of Pneumocystis jirovecii in critically ill patients with COVID-19Alanio A. ; Dellière S. ; Voicu S. ; Bretagne S. ; Mégarbane B.2021Journal of Infection
82 (4), pp. 84-123
Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19Issa H. et al.2021Frontiers in Medicine
8, 620990
SARS-CoV-2 viral dynamics in non-human primatesGonçalves A. et al.2021PLoS Computational Biology
17 (3), e1008785
Genomic characterization and phylogenetic analysis of the first SARS-CoV-2 variants introduced in LebanonFeghali R. et al.2021PeerJ
9, 11015
SARS-CoV-2 variants and ending the COVID-19 pandemicFontanet A. et al.2021The Lancet
397 (10278), pp. 952-954
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021Gaymard A. et al.2021Eurosurveillance
26 (9)
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionBrouwer P.J.M. et al.2021Cell
184 (5), pp. 1188-1200.e19
Maturation and persistence of the anti-SARS-CoV-2 memory B cell responseSokal A. et al.2021Cell
184 (5), pp. 1201-1213.e14
Association of Intravenous Immunoglobulins plus Methylprednisolone vs Immunoglobulins Alone with Course of Fever in Multisystem Inflammatory Syndrome in ChildrenOuldali N. et al.2021JAMA - Journal of the American Medical Association
325 (9), pp. 855-864
Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 among Healthcare Workers of a French University Hospital in Paris, FranceContejean A. et al.2021Open Forum Infectious Diseases
8 (3)
Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021Adlhoch C. et al.2021Eurosurveillance
26 (11), pp. 1-8
A self-assessment web-based app to assess trends of the COVID-19 pandemic in France: Observational studyDenis F. et al.2021Journal of Medical Internet Research
23 (3), e26182
Is This a Healthy Scientific Controversy or the "savior" Syndrome at Play? COVID-19 and the Hydroxychloroquine ExampleBoneca I.G.2021Microbial Drug Resistance
27 (3), pp. 279-280
Factors associated with severe SARS-CoV-2 infectionOuldali N. et al.2021Pediatrics
147 (3), e2020023432
COVID-19 Job Exposure Matrix From the Mat-O-Covid Design to Its ExecutionFadel M. ; Salomon J. ; Descatha A.2021Journal of Occupational and Environmental Medicine
63 (3), pp. E168
COVID-19 vaccination for cancer patients: Medical and ethical needSpano J.P. ; Barre-Sinoussi F. ; Kieny M.P. ; Marcelin A.G. ; Blay J.Y.2021Bulletin du Cancer
108 (3), pp. 225-227
Parallel trends in the transmission of SARS-CoV-2 and retail/recreation and public transport mobility during non-lockdown periodsCazelles B. ; Comiskey C. ; Nguyen-Van-Yen B. ; Champagne C. ; Roche B.2021International Journal of Infectious Diseases
104, pp. 693-695
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazinePlaze M. et al.2021International Journal of Antimicrobial Agents
57 (3), 106274
To quarantine, or not to quarantine: A theoretical framework for disease control via contact tracingLunz D. ; Batt G. ; Ruess J.2021Epidemics
34, 100428
Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2Fertitta L. et al.2021Journal of the European Academy of Dermatology and Venereology
35 (3), pp. e164-e167
Biostatistics to better detect fishy findingsTarantola A. ; Gautier L.2021The Lancet Infectious Diseases
21 (3), pp. 316-317
Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU – A case reportGhelfenstein-Ferreira T. et al.2021Medical Mycology Case Reports
31, pp. 15-18
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AWhite K.M. et al.2021Science
371 (6532), pp. 926-931
Covid-19: Keeping schools as safe as possibleFontanet A. ; Grant R. ; Greve-Isdahl M. ; Sridhar D.2021The BMJ
372, n524
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal modelsKu M.W. et al.2021Cell Host and Microbe
29 (2), pp. 236-249.e6
The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiomeBrett Finlay B. et al.2021Proceedings of the National Academy of Sciences of the United States of America
118 (6), e2010217118
Age-specific mortality and immunity patterns of SARS-CoV-2O’Driscoll M. et al.2021Nature
590 (7844), pp. 140-145
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning studyRosado J. et al.2021The Lancet Microbe
2 (2), pp. e60-e69
Persistent bilateral Tapia syndrome following critical COVID-19Yatim N. ; Bonnet N. ; Wing Tin S.N. ; Cohen Y. ; Degos B.2021Clinical Neurophysiology
132 (2), pp. 505-506
Institut Pasteur International Network's efforts to guide control measures against the coronavirus disease 2019 (COVID-19) epidemic among healthcare workers in AfricaRandremanana R. et al.2021International Journal of Infectious Diseases
103, pp. 525-526
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma PatientSzwebel T.A. et al.2021Stem Cell Reviews and Reports
17 (1), pp. 296-299
When Therapeutic IgA Antibodies Might Come of AgeSterlin D. ; Gorochov G.2021Pharmacology
106 (1-2), pp. 9-19
Evaluating the motivation of Red Cross Health volunteers in the COVID-19 pandemic: A mixed-methods study protocolHeyerdahl L.W. et al.2021BMJ Open
11 (1), e042579
IgA dominates the early neutralizing antibody response to SARS-CoV-2Sterlin D. et al.2021Science Translational Medicine
13 (577), eabd2223
Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions among Healthcare Workers of Adult and Pediatric Settings in Central ParisContejean A. et al.2021Clinical Infectious Diseases
72 (2), pp. 257-264
Early phylodynamics analysis of the COVID-19 epidemic in FranceDanesh G. et al.2021Peer Community Journal
1, e45
Urban-Rural Disparities for COVID-19: Evidence from 10 Countries and Areas in the Western PacificPark M. ; Lim J.T. ; Wang L. ; Cook A.R. ; Dickens B.L.2021Health Data Science
2021, 9790275
Use of lentiviral vectors in vaccinationKu M.W. ; Charneau P. ; Majlessi L.2021Expert Review of Vaccines
20 (12), pp. 1571-1586
Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2Scoca V. ; Di Nunzio F.2021Journal of Molecular Cell Biology
13 (4), pp. 259-268
Origin, evolution and global spread of SARS-CoV-2Zhukova A. et al.2021Comptes Rendus - Biologies
344 (1), pp. 57-75
Structure-function relations of the sars-cov-2 spike protein and impact of mutations in the variants of concernRey F.2021Comptes Rendus - Biologies
344 (1), pp. 77-110
SARS-CoV-2 infection in schools in a northern French city: A retrospective serological cohort study in an area of high transmission, France, January to April 2020Fontanet A. et al.2021Eurosurveillance
26 (15), pp. 1-12
Improving care of migrants is key for viral hepatitis elimination in europeKim J.U. ; Ingiliz P. ; Shimakawa Y. ; Lemoine M.2021Bulletin of the World Health Organization
99 (4), pp. 280-286
SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiotaSokol H. et al.2021Gut Microbes
13 (1), pp. 1-19
Addressing vulnerabilities in communities facing infectious disease threats: A need for social science-driven assessmentsOsborne J. et al.2021Journal of Global Health
11, pp. 1-4
A Conceptual Discussion about the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare SettingsTemime L. et al.2021Clinical Infectious Diseases
72 (1), pp. 141-143
Correction to: IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 (Journal of Clinical Immunology, (2021), 41, 1, (26-27), 10.1007/s10875-020-00933-0)Lévy R. et al.2021Journal of Clinical Immunology
41 (1), pp. 28
Impact of the lockdown on the burden of COVID-19 in outpatient care in France, spring 2020Souty C. et al.2021Infectious Diseases
53 (5), pp. 376-381
Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplificationGarneret P. et al.2021PLoS ONE
16 (1 January), e0243712
Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 PandemicAllali S. ; Cohen J.F. ; Brice J. ; Khraiche D. ; Toubiana J.2021Clinical Chemistry
67 (1), pp. 54-58
IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2Lévy R. et al.2021Journal of Clinical Immunology
41 (1), pp. 26-27
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in ParisAnna F. et al.2021European Journal of Immunology
51 (1), pp. 180-190
Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemicBaay M. et al.2021Biologicals
69, pp. 76-82
Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191–93Vieira M. et al.2021Joint Bone Spine
88 (1), 105074
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive SpikeSchoof M. et al.2020Science
370 (6523), pp. 1473-1479
Reconstruction of Transmission Pairs for Novel Coronavirus Disease 2019 (COVID-19) in Mainland China: Estimation of Superspreading Events, Serial Interval, and Hazard of InfectionXu X.K. et al.2020Clinical Infectious Diseases
71 (12), pp. 3163-3167
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsGordon D.E. et al.2020Science
370 (6521), eabe9403
Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: A retrospective matched case–control study, Paris, France, April to May 2020Toubiana J. et al.2020Eurosurveillance
25 (48)
Impact of mass testing during an epidemic rebound of SARS-CoV-2: A modelling study using the example of FranceBosetti P. et al.2020Eurosurveillance
26 (1)
Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virusCocozza F. et al.2020Journal of Extracellular Vesicles
10 (2), e12050
The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 CrisisCoutard B. et al.2020Biopreservation and Biobanking
18 (6), pp. 561-569
Optimizing COVID-19 surveillance in long-term care facilities: a modelling studySmith D.R.M. et al.2020BMC Medicine
18 (1), 386
A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX)Mazhari R. et al.2020PLoS ONE
15 (12 December), e0238010
What causes hidradenitis suppurativa ?—15 years afterZouboulis C.C. et al.2020Experimental Dermatology
29 (12), pp. 1154-1170
Survival of the Wealthiest?Garfinkel M. ; Sansonetti P.J. ; Pulverer B.2020EMBO Journal
39 (23), e107227
Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel?Montravers P. ; Kantor E. ; Gouel-Cheron A.2020Anaesthesia Critical Care and Pain Medicine
39 (6), pp. 695-697
Syncytia formation by SARS-CoV-2-infected cellsBuchrieser J. et al.2020EMBO Journal
39 (23), e106267
Complement C5 inhibition in patients with COVID-19 - A promising target?de Latour R.P. et al.2020Haematologica
105 (12), pp. 2847-2850
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severityHuang A.T. et al.2020Nature Communications
11 (1), 4704
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campusTemmam S. et al.2020One Health
10, 100164
SARS-CoV-2 natural transmission from human to Cat, Belgium, March 2020Garigliany M. et al.2020Emerging Infectious Diseases
26 (12), pp. 3069-3071
Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms (Scientific Data, (2020), 7, 1, (136), 10.1038/s41597-020-0477-8)Ostaszewski M. et al.2020Scientific Data
7 (1), 247
COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanismsOstaszewski M. et al.2020Scientific Data
7 (1), 136
Epidemiological data from the COVID-19 outbreak, real-time case informationXu B. et al.2020Scientific Data
7 (1), 106
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanismsTortorici M.A. et al.2020Science
370 (6519), pp. 950-957
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyPiccoli L. et al.2020Cell
183 (4), pp. 1024-1042.e21
Implementation of a self-triage web application for suspected COVID-19 and its impact on emergency call centers: Observational studyGalmiche S. et al.2020Journal of Medical Internet Research
22 (11), e22924
COVID-19 and vaccination: A global disruptionBillon-Denis E. ; Tournier J.N.2020Medecine/Sciences
36 (11), pp. 1034-1037
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept studyAnnane D. et al.2020EClinicalMedicine
28, 100590
Brief comparative evaluation of six open one-step RT-qPCR mastermixes for the detection of SARS-CoV-2 RNA using a Taqman probeHaddar C. ; Verhoeven P.O. ; Bourlet T. ; Pozzetto B. ; Pillet S.2020Journal of Clinical Virology
132, 104636
Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan AfricaLemoine M. et al.2020The Lancet Gastroenterology and Hepatology
5 (11), pp. 966-967
Clustering and superspreading potential of SARS-CoV-2 infections in Hong KongAdam D.C. et al.2020Nature Medicine
26 (11), pp. 1714-1719
A review of the main histopathological findings in coronavirus disease 2019Vasquez-Bonilla W.O. et al.2020Human Pathology
105, pp. 74-83
Animal and translational models of SARS-CoV-2 infection and COVID-19Johansen M.D. et al.2020Mucosal Immunology
13 (6), pp. 877-891
First detection and genome sequencing of SARS-CoV-2 in an infected cat in FranceSailleau C. et al.2020Transboundary and Emerging Diseases
67 (6), pp. 2324-2328
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patientsSmadja D.M. et al.2020Angiogenesis
23 (4), pp. 611-620
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Zhang Q. et al.2020Science
370 (6515), eabd4570
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Bastard P. et al.2020Science
370 (6515), eabd4585
Lockdown impact on COVID-19 epidemics in regions across metropolitan FranceCauchemez S. ; Kiem C.T. ; Paireau J. ; Rolland P. ; Fontanet A.2020The Lancet
396 (10257), pp. 1068-1069
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donationCappy P. et al.2020Blood
136 (16), pp. 1888-1891
COVID-19 herd immunity: where are we?Fontanet A. ; Cauchemez S.2020Nature Reviews Immunology
20 (10), pp. 583-584
Monitoring approaches for health-care workers during the COVID-19 pandemicBielicki J.A. et al.2020The Lancet Infectious Diseases
20 (10), pp. e261-e267
Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100TM SystemHourdel V. et al.2020Frontiers in Microbiology
11, 571328
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primatesMaisonnasse P. et al.2020Nature
585 (7826), pp. 584-587
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Silvin A. et al.2020Cell
182 (6), pp. 1401-1418.e18
A comprehensive, flexible collection of SARS-CoV-2 coding regionsKim D.K. et al.2020G3: Genes, Genomes, Genetics
10 (9), pp. 3399-3402
Modeling the inactivation of viruses from the Coronaviridae family in response to temperature and relative humidity in suspensions or on surfacesGuillier L. et al.2020Applied and Environmental Microbiology
86 (18), e01244
COVID-19 in Patients on Maintenance Dialysis in the Paris RegionTortonese S. et al.2020Kidney International Reports
5 (9), pp. 1535-1544
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceFafi-Kremer S. et al.2020EBioMedicine
59, 102915
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysisOuldali N. et al.2020The Lancet Child and Adolescent Health
4 (9), pp. 662-668
Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paperMaillard J.Y. et al.2020American Journal of Infection Control
48 (9), pp. 1090-1099
Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventionsAli S.T. et al.2020Science
369 (6507), pp. 1106-1109
Characterization of accessory genes in coronavirus genomesMichel C.J. ; Mayer C. ; Poch O. ; Thompson J.D.2020Virology Journal
17 (1), 131
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patientsHadjadj J. et al.2020Science
369 (6504), pp. 718-724
The Global Phosphorylation Landscape of SARS-CoV-2 InfectionBouhaddou M. et al.2020Cell
182 (3), pp. 685-712.e19
A race against the clock: Creation of SARS-CoV-2 in the laboratory, a month after its emergence!Iseni F. ; Tournier J.N.2020Medecine/Sciences
36 (8-9), pp. 797-801
An Old Cytokine against a New VirusPellegrini S. ; Uzé G.2020Journal of Interferon and Cytokine Research
40 (8), pp. 425-428
Structural insight into the role of novel SARSCoV-2 E protein: A potential target for vaccine development and other therapeutic strategiesSarkar M. ; Saha S.2020PLoS ONE
15 (8 August), e0237300
Delayed laboratory response to COVID-19 caused by molecular diagnostic contaminationMögling R. et al.2020Emerging Infectious Diseases
26 (8), pp. 1944-1946
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohortPouletty M. et al.2020Annals of the Rheumatic Diseases
79 (8), pp. 999-1006
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionVerweij P.E. et al.2020Intensive Care Medicine
46 (8), pp. 1524-1535
Minimising COVID-19 exposure during tracheal intubation by using a transparent plastic box: A randomised prospective simulation studyClariot S. ; Dumain G. ; Gauci E. ; Langeron O. ; Levesque É.2020Anaesthesia Critical Care and Pain Medicine
39 (4), pp. 461-463
A SARS-CoV-2 protein interaction map reveals targets for drug repurposingGordon D.E. et al.2020Nature
583 (7816), pp. 459-468
Estimating the burden of SARS-CoV-2 in FranceSalje H. et al.2020Science
369 (6500), pp. 208-211
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyPinto D. et al.2020Nature
583 (7815), pp. 290-295
Interplay between SARS-CoV-2 and the type I interferon responseRibero M.S. ; Jouvenet N. ; Dreux M. ; Nisole S.2020PLoS Pathogens
16 (7), e1008737
Knowledge, attitude, and perceptions towards the 2019 Coronavirus Pandemic: A bi-national survey in AfricaHager E. et al.2020PLoS ONE
15 (7 July), e0236918
Planetary health: young academics ask universities to actWabnitz K.J. et al.2020The Lancet Planetary Health
4 (7), pp. e257-e258
SARS-CoV-2: Virology, epidemiology, immunology and vaccine developmentBaay M. et al.2020Biologicals
66, pp. 35-40
A hybrid approach to tracheostomy in COVID-19 patients ensuring staff safetyTanaka L. et al.2020British Journal of Surgery
107 (8), pp. e253-e254
Working from home in the time of COVID-19: How to best preserve occupational health?Bouziri H. et al.2020Occupational and Environmental Medicine
77 (7), pp. 509-510
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 PatientsBost P. et al.2020Cell
181 (7), pp. 1475-1488.e12
Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliableMavian C. et al.2020Proceedings of the National Academy of Sciences of the United States of America
117 (23), pp. 12522-12523
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational studyToubiana J. et al.2020BMJ (Clinical research ed.)
369, pp. m2094
Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery studyPlaze M. et al.2020Encephale
46 (3), pp. S35-S39
French psychiatry and the novelty of the COVID-19 crisisMasson M. ; Gaillard R.2020Encephale
46 (3), pp. S1-S2
Epidemiological Observations on the Association between Anosmia and COVID-19 Infection: Analysis of Data from a Self-Assessment Web ApplicationDenis F. et al.2020Journal of Medical Internet Research
22 (6), e19855
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19Alanio A. ; Dellière S. ; Fodil S. ; Bretagne S. ; Mégarbane B.2020The Lancet Respiratory Medicine
8 (6), pp. e48-e49
Repurposing chlorpromazine to treat COVID-19: The reCoVery studyPlaze M. et al.2020Encephale
46 (3), pp. 169-172
Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseasesvon Lilienfeld-Toal M. et al.2020Leukemia
34 (6), pp. 1487-1494
Preliminary observations of anaesthesia ventilators use for prolonged mechanical ventilation in intensive care unit patients during the COVID-19 pandemicGouel-Cheron A. ; Couffignal C. ; Elmaleh Y. ; Kantor E. ; Montravers P.2020Anaesthesia Critical Care and Pain Medicine
39 (3), pp. 371-372
Invasive fungal diseases during COVID-19: We should be preparedGangneux J.P. ; Bougnoux M.E. ; Dannaoui E. ; Cornet M. ; Zahar J.R.2020Journal de Mycologie Medicale
30 (2), 100971
Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesLescure F.X. et al.2020The Lancet Infectious Diseases
20 (6), pp. 697-706
Serial interval of COVID-19 among publicly reported confirmed casesDu Z. et al.2020Emerging Infectious Diseases
26 (6), pp. 1341-1343
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 PatientsBonam S.R. ; Kaveri S.V. ; Sakuntabhai A. ; Gilardin L. ; Bayry J.2020Cell Reports Medicine
1 (2), 100016
COVID-19, chronicle of an expected pandemicSansonetti P.J.2020EMBO Molecular Medicine
12 (5), e12463
Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assaysCrawford K.H.D. et al.2020Viruses
12 (5), 513
The effect of human mobility and control measures on the COVID-19 epidemic in ChinaKraemer M.U.G. et al.2020Science
368 (6490), pp. 493-497
Chloroquine and COVID-19, where do we stand?Lecuit M.2020Medecine et Maladies Infectieuses
50 (3), pp. 229-230
Risk for transportation of coronavirus disease from Wuhan to other cities in ChinaDu Z. et al.2020Emerging Infectious Diseases
26 (5), pp. 1049-1052
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinWalls A.C. et al.2020Cell
181 (2), pp. 281-292.e6
Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020Boëlle P.Y. et al.2020Eurosurveillance
25 (14), 2000326
Facing challenges with the novel coronavirus SARS-CoV-2 outbreakvan der Werf S. ; Peltekian C.2020Virologie (Montrouge, France)
24 (S1), pp. e12-e15
Coronavirus outbreak: the role of companies in preparedness and responsesFadel M. ; Salomon J. ; Descatha A.2020The Lancet Public Health
5 (4), pp. e193
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020Spiteri G. et al.2020Eurosurveillance
25 (9), 2000178
First cases of coronavirus disease 2019 (COVID-19) in France: Surveillance, investigations and control measures, January 2020Stoecklin S.B. et al.2020Eurosurveillance
25 (6), 2000094
Development of vaccines at the time of COVID-19Almond J. et al.2020MicroLife
1 (1), uqaa003
COVID-19 and socioeconomic development in Africa: The first 6 months (february 2020-august 2020)Garenne M.M.2020International Journal of Population Studies
6 (2), pp. 1-14
Highly performing point-of-care molecular testing for sars-cov-2 with RNA extraction and isothermal amplificaitonCoz E. et al.2020MicroTAS 2020 - 24th International Conference on Miniaturized Systems for Chemistry and Life Sciences
, pp. 1232-1233
Rapid detection of COVID-19 by serological methods and the evaluation of diagnostic efficacy of IgM and IgGHuang S. et al.2020Clinical Laboratory
66 (11), pp. 2327-2333
Pandemic legion history more complex than previously thoughtTournier J.N.2020mBio
11 (5), e02377-20
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populationsGrzelak L. et al.2020Science Translational Medicine
12 (559), eabc3103
Randomized controlled study evaluating efficiency of low intensity transcranial direct current stimulation (TDCS) for dyspnea relief in mechanically ventilated COVID-19 patients in ICU: The tDCS-DYSP-COVID protocolAzabou E. et al.2020Frontiers in Medicine
7, 372
Introductions and early spread of SARS-CoV-2 in france, 24 january to 23 march 2020Gámbaro F. et al.2020Eurosurveillance
25 (26)
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implicationsChangeux J.P. ; Amoura Z. ; Rey F.A. ; Miyara M.2020Comptes Rendus - Biologies
343 (1), pp. 33-39
Retour en haut